References
- DeBold A J, Borenstein H B, Veress A T, Sonnenberg I IB. A rapid potent natriuretic response to intravenous injection of atrial myocardial extract. Life Sci 1981; 28: 89–94
- Garcia R, Thibault G, Cantin M, Genest J. Effect of purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds. Am J Physiol 1984; 427: R34–R39
- Maack T, Manon D N, Camargo M JF. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function and the renin-aldosterone system in dogs. Am J Med. 1984; 77: 1069–1075
- Kurtz A, Bruna R D, Pfeilschifter J, Taugner R, Bauer C. Atrial natriuretic peptid inhibits renin release from juxta-glomerular cells by a cGMP mediated process. Proc Nat Acad Sci USA 1986; 83: 4769–4773
- Atrashi K, Mulrow P J, Franco-Saenz R, Snadjar R, Rapp J. Inhibition of aldosterone production by an atrial extract. Science 1984; 224: 992–993
- Kleinert H D, Maack T, Atlas S A, Januszewicz A, Sealey J E, Laragh J H. Atrial natriuretic factor inhibits angiotensin, norepinephrine and potassium induced vascular contractility. Hypertension 1984; 6: 1–5
- Zacharian P K, Burnett J C, Ritter S G, Strong C G. Atrial natriuretic peptide in human essential hypertension. Mayo Clin Proc 1987; 62: 782–786
- van Hooft I, Schiffers P, Grenoble D E, Rahn H, Hofman A. Similar plasma atrial natriuretuc factor in children and in young adults with a high and low probabiliy of developing hypetension. J of Hypertension 1989; 7(suplement 1)543–544
- Larochelle P, Cusson J R, Gutkowska J, Schiffrin E L, Hamet P, Kuchel O, Genest J, Cantin M. Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. Br Med J 1987; 294: 1249–1252
- Matsubara H, Mori Y, Takashima H, Inada M. Simultaneous measurement of alpha-human atrial natriuretic factor (hANF) and NH2-terminal fragment of pro-hANF in essential hypertension. Am Heart J 1989; 118: 494–499
- Kohno M, Yasunari K, Matsuura T, Murakawa K, Takeda T. Circulating atrial natriuretic polypeptide in essential hypertension. Am Heart J 1987; 113: 1160–1163
- Sagnella G A, Markandu N D, Shore A C, McGregor G A. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1986; 1: 179–180
- Sugawara A, Nakao K, Sakamoto M, Imura H. Plasma concentration of atrial natriuretic polypeptide in essential hypertension. Lancet 1985; 2: 1426–1428
- Sugawara A, Nakao K, Kono T, Morii N, Yamada T, Inoh H, Shiono S, Saito Y, Mukoyama M, Arai H, Imura H. Atrial natriuretic factor in essential hypertension and adrenal disorders. Hypertension 1988; 11(suppl 1)1212–1216
- Richards A M, Tonolo G, Davidson G, Tillman D, Conmell J M, Robertson J S. Plasma atrial natriuretic peptide in essential hypertension (abstract). Hypertension 1986; 8: S26
- Ambulatory blood pressure monitoring, M A Weber, J M Drayer. Springer-Verlag, N.Y 1984
- Nishiuchi T, Saito H, Yamasaki Y, Saito S. Radio-immunoassay for atrial natriuretic peptide: method and results in normal subjects and patients with various diseases. Clin Chim Acta 1986; 159: 45–49
- Ferrier C, Weidmann P, Hollmann D, Dietler R, Shaw S. Impaired response of atrial natriuretic factor to high salt intake in persons prone to hypertension. Lancet 1988; 319: 1223–1224